文献速递免疫规划职业卫生卫生政策与健康促进

法国医疗行业工作者在新冠疫情期间疫苗接受度的7C心理前因分析:重复横断面研究(CappVac-Cov)

Analyzing the 7C psychological antecedents of vaccine acceptance throughout the COVID-19 pandemic among healthcare sector workers in France: A repeated cross-sectional study (CappVac-Cov).
PubMed 文献 · Vaccine · 2024-07-06

该研究在法国医疗行业工作者中开展四轮重复横断面网络调查(P1至P4分别纳入5234、339、351和437人),评估7C心理前因与疫苗加强针接种意愿/行为的关联。结果显示不同阶段主要前因不同:早期为获益-风险感知(aPR 2.32)、对雇主鼓励的逆反(aPR 2.23)、疫苗信心(aPR 1.71)和社交从众(aPR 1.33);强制接种期间仅集体行动感知与当前接种状态相关(aPR 2.19);后期加强针意愿与获益-风险感知(aPR 2.07)和集体行动感知(aPR 1.69)强相关。害怕严重副作用使人群疫苗意愿降低26.2%。作者认为7C前因及其与疫苗行为的关联随时间变化,强调确保疫苗安全性信心的重要性。

要点

  • 早期疫苗意愿主要前因包括获益-风险感知(aPR 2.32)、逆反(aPR 2.23)、信心(aPR 1.71)和从众(aPR 1.33)。
  • 强制接种期间仅集体行动感知与当前接种状态相关(aPR 2.19)。
  • 后期加强针意愿与获益-风险感知(aPR 2.07)和集体行动感知(aPR 1.69)强相关。

核心结论

  • 作者认为7C心理前因及其与疫苗行为的关联可随时间变化,并强调确保疫苗安全性信心的重要性。

研究设计与样本

  • 由医疗行业工作者职业感染预防研究组(GERES)通过电子邮件链式转介于法国全境医疗行业工作者中开展三轮重复网络调查,调查时间分别为2021年7-11月、2022年2-3月和2023年1-3月(P2、P3、P4)。
  • 重新分析了先前于2020年底至2021年初开展的类似研究数据(Moirangthem等,2022)(P1)。
  • 四轮调查(P1-P4)分别纳入5234、339、351和437名参与者。
  • 采用稳健方差泊松回归估计调整患病率比(aPR),评估7C条目与未来疫苗接种意愿/行为的关联,并报告7C条目的人群归因疫苗意愿损失。

主要发现

  • 疫苗运动早期,疫苗意愿的主要前因包括对疫苗接种获益-风险平衡(BRB)的有利感知(对比不利,aPR:2.32)、对雇主鼓励接种的逆反(激励对比劝退,aPR:2.23)、疫苗信心(对比无信心,aPR:1.71)以及对疫苗接种的社会从众(对比私人环境中的怀疑观点,aPR:1.33)。
  • 在针对医疗行业工作者的疫苗强制接种期间,仅将接种视为集体行动与当前疫苗接种状态相关(同意对比不同意,aPR:2.19)。
  • 疫情后期,假设性加强针接种意愿与BRB感知(有利对比不利,aPR:2.07)和集体行动感知(同意对比不同意,aPR:1.69)强相关。
  • 害怕疫苗接种的严重副作用使人群疫苗意愿降低26.2%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Across various stages of the COVID-19 pandemic and related vaccine recommendations in France, we assessed the association of the 7C-psychological antecedents with vaccine uptake/intention for booster vaccination among healthcare-sector workers (HCSWs). We also assessed whether 7C-antecedent profiles changed over time. METHODOLOGY: The Research Group for the Prevention of Occupational Infections in Healthcare Workers (GERES) conducted three repeated web-surveys which were disseminated by email chain-referral among HCSWs throughout France. The questionnaires waves took place: July-November 2021, February-March 2022 and January-March 2023 (P2, P3 and P4). We also reanalysed data from a prior similar study conducted late 2020-early 2021 (Moirangthem et al. (2022)) (P1). To evaluate the association of 7C-items with vaccine uptake-intention for future vaccination, we estimated adjusted prevalence ratios (aPR) using robust variance Poisson regression. We report the 7C-item population attributable loss in vaccine intention. RESULTS: The four surveys (P1-P4) encompassed 5234, 339, 351 and 437 participants. At earlier stages of the vaccine campaign, the principal antecedents of vaccine intention were favorable perception of vaccination benefit-risk-balance (BRB) (vs. unfavorable, aPR: 2.32), reactance to employer encouragement for vaccination (motivates vs. dissuades-me, aPR:2.23), vaccine confidence (vs. not-being-confident, aPR: 1.71) and social conformism towards vaccination (favorable vs. skeptical opinion in private environment, aPR: 1.33). Under a vaccine mandate for HCSWs, only perceiving vaccination as a collective action was associated with current vaccine status (agree vs. disagree, aPR: 2.19). At later stages of the epidemic, hypothetical booster vaccine intentions were strongly associated with BRB perception (favorable vs. unfavorable, aPR: 2.07) and perceiving vaccination as a collective action (agree vs. disagree, aPR: 1.69). Fearing a severe side effect from vaccination decreased population vaccine intention by 26.2 %. CONCLUSION: Our results suggest that both 7C-antecedents and their association with vaccine behaviour can change over time, and underscore the importance of assuring confidence in vaccine safety.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Araujo-Chaveron L, Olivier C, Pellissier G, et al. Analyzing the 7C psychological antecedents of vaccine acceptance throughout the COVID-19 pandemic among healthcare sector workers in France: A repeated cross-sectional study (CappVac-Cov). Vaccine. 2024. PMID: 38972764. doi:10.1016/j.vaccine.2024.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。